QLC5508: Clinical Trials

2 trials of QLC5508, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting. 2 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Recruiting 2
Phase 22Recruiting 2

Follow QLC5508: new trials by email Literature Review of QLC5508 trials Research Report on QLC5508

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Clinical Study of QLC5508 and/or QLH12016 in Combination With Other Anti-tumor Therapies in Subjects With Advanced Prostate Cancer
QLC5508, abiraterone acetate, enzalutamide - Advanced Prostate Cancer
Phase 1 / Phase 2RecruitingQilu Pharmaceutical Co., Ltd.2122025-11-052026-06-02
A Study of QLC5508 Combinations in Patients With Advanced Solid Tumors
QLC5508, QL1706, Cisplatin/ Carboplatin - Advanced Solid Tumor
Phase 1 / Phase 2RecruitingQilu Pharmaceutical Co., Ltd.4442025-10-242025-12-01

Sponsors

Qilu Pharmaceutical Co., Ltd. (2)

Countries

China (2)